phrykt

HeartBeam, Inc. (BEAT): who owns it and who trades it

As of Oct 30, 2026, BEAT insiders reported 3 open-market sales worth $1.1M and 7 purchases worth $901K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Mark E Strome (10% owner), with $895K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, BEAT insiders reported $901K of open-market purchases and $1.1M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$901K
7 trades, 6 people
Sales, 12 months
$1.1M
3 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Apr 16, 2026
Filed Apr 24, 2026

Purchases and sales by month

$1.1M$1.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Apr 16, 2026Richard FerrariDirectorPurchase57,500$0.80$46KForm 4
Apr 16, 2026Tim CruickshankCFOPurchase31,250$0.80$25KForm 4
Apr 16, 2026Willem ElfrinkDirectorPurchase187,500$0.80$150KForm 4
Apr 16, 2026Richard FerrariDirectorPurchase62,500$0.80$50KForm 4
Apr 16, 2026Robert Paul ENOPresidentPurchase12,500$0.80$10KForm 4
Apr 16, 2026Marga Ortigas-WedekindDirectorPurchase25,000$0.80$20KForm 4
Apr 16, 2026Mark E StromeDirectorPurchase750,000$0.80$600KForm 4
Dec 18, 2025Urioste George deDirectorSale33,185$2.83$93.9KForm 4
Dec 17, 2025Mark E Strome10% ownerSale250,000$3.58$895KForm 4
Dec 17, 2025Urioste George deDirectorSale23,961$3.68$88.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Mark E Strome10% owner$600K$895KApr 16, 2026
Urioste George deDirector–$182KDec 18, 2025
Willem ElfrinkDirector$150K–Apr 16, 2026
Richard FerrariDirector$96K–Apr 16, 2026
Tim CruickshankCFO$25K–Apr 16, 2026
Marga Ortigas-WedekindDirector$20K–Apr 16, 2026
Robert Paul ENOPresident$10K–Apr 16, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BEAT short interest

Low short interest. 4.0% of BEAT shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went down 12%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 2.27M BEAT shares were sold short, 4.0% of the shares outstanding, down 8.6% from the report before. At the average daily volume of 1.42M shares, buying them all back would take about 1.6 trading days (days to cover).

Shares short, % of all shares

4.03%May 15Oct 306.74%

Days to cover

1.6May 15Oct 307.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.27M4.03%-9%1.42M1.6
Oct 15, 20262.48M4.41%-0%39.68M1.0
Sep 30, 20262.49M4.43%+17%400,9126.2
Sep 15, 20262.12M3.77%+9%414,0775.1
Aug 31, 20261.94M3.45%-20%303,3836.4
Aug 14, 20262.43M4.31%+32%604,7784.0
Jul 31, 20261.84M4.47%-28%398,3214.6
Jul 15, 20262.54M6.19%+42%1.69M1.5
Jun 30, 20261.79M4.36%-16%628,6272.9
Jun 15, 20262.13M5.19%-7%696,4003.1
May 29, 20262.30M5.59%-11%472,1214.9
May 15, 20262.59M6.31%-11%878,3373.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

HeartBeam company events

HeartBeam filed 8 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, listing). The latest was on Aug 14, 2026.

  1. Aug 14, 2026AgreementHeartBeam, Inc., entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC, as sales agent, pursuant to which the Company may sell, from time to time, an aggregate of up to $25 million of its common stock, par value $0.0001 per share. Filing
  2. Aug 6, 2026LeadershipAmended an earlier report. That it was expected that the Company and Robert P. Eno would enter into a consulting agreement, and that any payment of the severance amounts pursuant to the terms of Mr. Eno’s Employment Agreement dated as of January 17, 2023 is subject to Mr. Eno’s execution of a release of claims satisfactory… Filing
  3. Aug 3, 2026VoteReported shareholder vote results. Filing
  4. Jul 2, 2026ListingHeartBeam, Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the last 30 consecutive business days, the Company is… Filing
  5. Jun 24, 2026LeadershipHeartbeam, Inc. and Mr. Eno mutually agreed to his departure as the Company’s Chief Executive Officer, as a member of the Company’s Board of Directors, and as the Company’s principal executive officer, effective as of June 30, 2026, in connection with a strategic reorganization within the Company. Filing
  6. Jun 22, 2026LeadershipThe Compensation Committee of the Board of Directors of HeartBeam, Inc. approved certain compensatory arrangements for Branislav Vajdic, the Company’s President, Founder and Director, including a performance-based restricted stock unit award and a transaction bonus agreement, each as described below. Filing
  7. Apr 16, 2026AgreementHeartBeam, Inc. entered into an underwriting agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC, pursuant to which the Company agreed to issue and sell in an underwritten public offering an aggregate of 12,500,000 shares of the Company’s common stock, par value… Filing
  8. Nov 21, 2025AnnouncementHeartBeam, Inc. received a Not Substantially Equivalent (NSE) letter from the U.S. Food and Drug Administration (FDA) related to the Company’s 510(k) application for its 12-Lead Electrocardiogram (ECG) Synthesis Software. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

HeartBeam financials

Questions about HeartBeam, Inc. (BEAT) stock

Are BEAT insiders buying or selling?

In the last 12 months, BEAT insiders reported 7 open-market purchases worth $901K and 3 sales worth $1.1M. The latest trade was on Apr 16, 2026. See every trade.

What is the short interest in BEAT?

As of Oct 30, 2026, 2.27M BEAT shares were sold short, 4.0% of the shares outstanding, down 8.6% from the report before. At the average daily volume of 1.42M shares, buying them all back would take about 1.6 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.